ClinicalTrials.gg
RecruitingNCT06890325GEROSUpdated Mar 24, 2025

A Service-Learning Program for Comprehensive Geriatric Assessment and Health Promotion in Older Adults

An interventional study of Comprehensive Geriatric Assessment (CGA) and Health education in Frailty, Older People and Comprehensive Geriatric Assessment, sponsored by University of Vic - Central University of Catalonia. Recruiting at 1 site in Spain. Open to participants aged 60 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-03-24.

Sponsored by University of Vic - Central University of Catalonia · Not applicable, Interventional, and Screening

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2025, 11 months ago, but the record still lists the study as recruiting.
  • Registered 3 months after the study started (first participant enrolled Nov 2024, registered Mar 2025).
  • Started Nov 2024; still recruiting 2 years later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Not applicable
Ages
60 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 132 studies in Frailty with a site in Spain — 46 open to participants now, 54 under way, none of them phase 3. Frailty · Spain.

Planned enrollment
46th of 96
100 · median 90
Started
2024
with 13 others
No phase
93 of 132
34 open now
Primary completion
2025-12
later than 17 of 53 live
Registered
83rd of 132
by date

Among the 132 studies in Frailty with a site in Spain, this one is the 46th largest by planned enrollment of the 96 interventional ones that give a count, is one of 14 that started in 2024, is one of 93 with no phase, reaches primary completion later than 17 of the 53 other live ones, and was the 83rd registered.

Frailty

1,291 studies on the registry are indexed under Frailty; 454 are open to participants now.

Browse Frailty studies →

Open to participants now

46 of the 132 studies in Frailty with a site in Spain are open now. Recruiting first, the newest first:

40 more — sign in →

All 46 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 299 Frailty studies recruiting now, 235 (79%) set no upper age limit and 10 (3%) stop at 75 or younger; 7 take children under 18; 66 take healthy volunteers.

This study: 60 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 132 studies in Frailty with a site in Spain, or all of them as a file.
02

Study summary

The GEROS Project aims to develop and implement a Service-Learning (S-L) program that integrates Comprehensive Geriatric Assessment (CGA) and health promotion, for students at the Faculty of Health Sciences and Welfare at the University of Vic - Central University of Catalonia (UVic-UCC). This initiative engages university students, healthcare professionals, and older adults (60+) in a participatory, intergenerational approach that fosters mutual learning and community engagement.

The study follows a non-experimental mixed-method design, involving students from Nursing, Physiotherapy, Human Nutrition and Dietetics, Occupational Therapy, and Psychology. Participants include older adults (60+) who can independently travel to the university.

The project is integrated into different subjects, in groups of 4-5 students, participants conduct a Comprehensive Geriatric Assessment (CGA), evaluating frailty using VIG-Frail, intrinsic capacity with ICOPE, quality of life with EUROQOL 5D-5L, and specific health indicators with Nursing Outcomes Classification (NOC).

To assess the program's effectiveness, several outcome measures will be analyzed including students' perceived knowledge, competencies, and skills, as well as older adults' awareness of their health status, lifestyle, and risk factors. Additionally, the satisfaction levels of both will be evaluated. The items will be evaluated using a 1-5 Likert Scale, and the analysis will be conducted with SPSS. Data recording will be carried out through REDCap.

The GEROS Project aligns with the United Nations' Sustainable Development Goals (SDGs), specifically SDG 3 (Good Health and Well-being) and SDG 10 (Reduced Inequalities). By offering care to the aging population and providing them with personalized health recommendations, the project promotes preventive strategies, active aging, and intergenerational learning.

Furthermore, GEROS integrates innovative educational methodologies, encouraging experiential learning, collaboration with healthcare professionals, and the development of practical skills in real-world contexts. The program's scalability and adaptability could serve as a model for other universities and healthcare institutions aiming to enhance geriatric care through service-learning initiatives.

03

Conditions studied

  • Frailty
  • Older People
  • Comprehensive Geriatric Assessment
  • Health Promotion
  • SERVICE LEARNING
  • Students
  • Student Education

Browse trials for

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

A) For users:

  • Any person aged 60 or older who can move to the facility (Faculty of Health Sciences and Welfare) independently or accompanied by a caregiver.

B) For students:

  • Students from Nursing, Physiotherapy, Nutrition and Dietetics, Occupational Therapy and Psychology degrees of UVic-UCC.

Exclusion criteria

Exclusion Criteria:

  • For users: Individuals institutionalized in a long-term care institution.
05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Comprehensive geriatric assessment.

    Comprehensive geriatric assessment.

    Diagnostic Test: Comprehensive Geriatric Assessment (CGA) · Behavioral: Health education

Interventions

  • Diagnostic testComprehensive Geriatric Assessment (CGA)

    The intervention will consist of a total of 3 sessions which will take place in different areas of the Faculty of Health and Welfare Sciences (FCSB) at the University of Vic - Central University of Catalonia. In Session 1, a comprehensive geriatric assessment (CGA) will be conducted to the users (by students supervised by health professionals).

  • BehavioralHealth education

    A report with the results of the CGA and health recommendations will be delivered to the users. They will receive health education including specific recommendations and community health resources based on their health status and CGGA.

06

What researchers measure

Primary outcomes

  1. Frailty

    VIG-Frail is a screening tool used to assess frailty in older adults. It's a short, easy-to-administer test that helps healthcare providers identify individuals who may be at risk of adverse health outcomes due to frailty.

    Time frame: Baseline assessment

  2. Users Satisfaction with treatment

    Evaluation of the user's general satisfaction with participating in the project (5-point Likert scale from 1-not at all to 5-very satisfied)

    Time frame: Up to 2-4 weeks (Post-intervention - 2nd session)

  3. Students Satisfaction with intervention

    Evaluation of the students' general satisfaction with the participation in the study (5-point Likert scale from 1-not at all to 5-very satisfied)

    Time frame: At the end of Session 1 (CGA of users)

Secondary outcomes

  1. Self-reported Quality of Life

    Quality of Life measured with EuroQol 5D-5L, a standardised tool used to measure and assess health-related quality of life. The "5D" refers to five dimensions of health: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five levels, ranging from "no problems" to "extreme problems," allowing for a detailed assessment of a person's health status.Health state index scores generally range from less than 0 (where 0 is the value of a health state equivalent to dead; negative values representing values as.

    Time frame: Baseline assessment

  2. Intrinsic capacity

    Integrated care for older people approach (ICOPE) is a framework developed by the World Health Organization to support the health and well-being of older adults through comprehensive, integrated care. It focuses on 7 key dimensions: cognitive decline, limited mobility, undernutrition, vision impairment, hearing loss, depressive symptoms, and social care and supports, as well as carer support and urinary incontinence. These areas are assessed to create a holistic care plan tailored to the individual's needs. This outcome will be categorized according to the number or preserved dimensions: from 7 (all 7 dimesions preserved) to 0 (all 7 dimensions affected).

    Time frame: Baseline assessment

  3. Nursing Outcomes Classification

    The NOC (Nursing Outcomes Classification) is a system used to assess the results of nursing care, helping to measure a person's level of functioning and well-being in different areas of health. The NOC outcomes evaluated in this context are: Cognition, Mobility, Nutritional Status, Sensory Function: Vision, Desire to Live, Caregiver Well-being Urinary Continence, Psychosocial Adjustment: Life Change These outcomes are assessed using a 5-point Likert scale, ranging from 1 (Not demonstrated) to 5 (Always demonstrated).

    Time frame: Baseline assessment

  4. Students Self-perception of increased knowledge, skills and competencies

    Knowledge about Health Promotion and Disease Prevention, Improvement in Skills and Technical Competencies in Comprehensive Geriatric Assessment (CGA), Skills and Technical Competencies in Intrinsic Capacity (ICOPE), Transversal Skill "Communication", Critical Thinking, Integration of Knowledge, Skills, and Competencies in the subject in Which the project Was Held, Problem-Solving Ability, Interdisciplinary. These outcomes are assessed using a 5-point Likert scale, ranging from 1 (Not demonstrated) to 5 (Always demonstrated).

    Time frame: At the end of Session 1 (CGA of users)

  5. Users Self-perception of increased knowledge, skills and competencies

    Knowledge about Their Own Health, Lifestyle and Risk Factors to Modify for increasing Health and Disease Prevention and Community Health Resources, evaluated with a Likert scale from 1 to 5 (1 = not much, 5 = very much)

    Time frame: Up to 2-4 weeks (Post-intervention - 2nd session)

07

Study locations

1 of 1 sites recruiting
  • Faculty of Health Sciences and Welfare
    Vic, Barcelona 08500, Spain
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2024 (actual). Primary completion is estimated for Dec 2025, 13 months after the start.

Of 514 non-industry interventional studies with no phase under Frailty, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 39. This study's planned 13 months is below that.

Counting every sponsor, half of 519 studies reached it within 22 months; a quarter within 10 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 5, 2025
First posted
Mar 24, 2025
StartActual
Nov 11, 2024
Primary completionEst.
Dec 20, 2025
CompletionEst.
Dec 20, 2025
Last update
Mar 24, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06890325
Lead sponsor
University of Vic - Central University of Catalonia
Responsible party
Javier Jerez Roig (Associate Professor, Head of the Research Group M3O, Care Area Coordinator of the IRIS-CC, University of Vic - Central University of Catalonia) — Principal investigator
First posted
Mar 24, 2025
Start date
Nov 11, 2024
Primary completion
Dec 20, 2025 (estimated)
Completion
Dec 20, 2025 (estimated)
Last update
Mar 24, 2025

Study contacts

Javier Jerez-Roig, Professor, PhD
Contact
javier.jerez@uvic.cat
+34938 816 025
Júlia Casacuberta-Roca, Nursing
study director · University of Vic - Central University of Catalonia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion